Mumbai: Pharmaceutical firm Cadila Healthcare on Tuesday reported a net profit of Rs60.53 crore for the third quarter (Q3) ended 31 December, while it had a net profit of Rs51.56 crore in the same period last fiscal.
Total sales and other income from operations rose to Rs749.10 crore for the quarter under review, from Rs579.53 crore in the same period last fiscal, Cadila Healthcare said in a filing to the Bombay Stock Exchange.
Last year, Cadila Healthcare had demerged its consumer products division and merged Zydus Hospitals and Medical Research with itself. Following the arrangement, the results of the quarter and nine-month ended are not comparable with that of the same period last year, the company said.
Pursuant to the restructuring, Carnation continues to remain a listed subsidiary of the parent firm.
During the nine month ended December 2008, the company reported a net profit of Rs245.08 crore, while it had a net profit of Rs205.64 crore in the corresponding period last fiscal.
Total income of the nine-month ended December 2008 rose to Rs2,204.09 crore, whereas it was Rs1,761.36 crore in the year-ago period.
Shares of Cadila Healthcare were trading at Rs244.50, up 2.43% on the BSE.